Pharm-Bio Serv Inc lost $0.00 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $0.00 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Pharm-Bio Serv Inc has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Pharm-Bio Serv Inc lost $0.00 per diluted share in fiscal year 2025.
Pharm-Bio Serv Inc (PBSV) reported a loss of $0.03 per diluted share in fiscal year 2024 and a loss of $0.00 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Pharm-Bio Serv Inc (PBSV) reported $0.00 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 15 fiscal years this page covers, Pharm-Bio Serv Inc (PBSV) diluted earnings per share went from $0.14 in fiscal year 2011 to $0.00 in fiscal year 2025.
Pharm-Bio Serv Inc (PBSV) reported $0.00 in diluted earnings per share in Q3 2026.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Pharm-Bio Serv Inc (PBSV) reported on that line in every period on record.
